At Oncopeptides we are committed to the development of therapies for difficult-to-treat hematological diseases. We strive to bring hope to patients through science and innovation. Every day we are inspired by the perseverance that we see from patients, caregivers and health care providers in their fight against cancer. We are unwavering in our focus and dedication to bring forward new and meaningful treatment options. Oncopeptides' headquarters is in Stockholm, Sweden with a U.S. headquarters in Waltham, Massachusetts, outside of Boston. In addition to Waltham, Oncopeptides has a footprint in Los Altos, California, another U.S. biotechnology hub.